Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $24.2M | $19.5M | $19.2M | $4.6M | $4.7M | |
| Gross Profit | $13M | $11.1M | $10.8M | $2.4M | $2.5M | |
| Operating Income | -$9.3M | -$3.1M | -$2.2M | -$249K | -$685.8K | |
| EBITDA | -$6.3M | -$1.3M | -$366.7K | -$173K | -$253.3K | |
| Diluted EPS | -$12.30 | -$4.53 | -$3.92 | -$2.35 | -$0.08 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $36.5M | $16M | $8.1M | $6.4M | $6.6M | |
| Total Assets | $124.9M | $40.8M | $16.2M | $10.6M | $10.4M | |
| Current Liabilities | $6.9M | $5.3M | $4.7M | $8.6M | $3.2M | |
| Total Liabilities | $21.7M | $9.4M | $7.2M | $8.6M | $3.2M | |
| Total Equity | $103.1M | $31.4M | $9M | $2M | $7.2M | |
| Total Debt | $6.1M | $3.7M | $2.4M | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$4.4M | -$428.8K | -$1.5M | $97.9K | -$240.7K | |
| Cash From Investing | $702.5K | -$290K | -$184.2K | -$110K | -$2.8K | |
| Cash From Financing | -$1.3M | $1.3M | $1.4M | -- | $1.4M | |
| Free Cash Flow | -$4.7M | -$718.8K | -$1.6M | -$12.1K | -$243.5K | |
cbdMD, Inc. engages in the business of operating cannabidiol brands such as Paw cannabidiol and cbdMD botanicals. Its product categories include CBD tinctures, gummies, topical, and bath bombs. The company was founded on March 17, 2015 and is headquartered in Charlotte, NC.
In the current month, YCBD has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The YCBD average analyst price target in the past 3 months is $2.00.
According to analysts, the consensus estimate is that cbdMD, Inc. share price will rise to $2.00 per share over the next 12 months.
Analysts are divided on their view about cbdMD, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that cbdMD, Inc. is a Sell and believe this share price will drop from its current level to $2.00.
The price target for cbdMD, Inc. over the next 1-year time period is forecast to be $2.00 according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
According to Wall Street analysts, the consensus rating for cbdMD, Inc. is a --. 0 of 0 analysts rate the stock a -- at this time.
You can purchase shares of cbdMD, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase cbdMD, Inc. shares.
cbdMD, Inc. was last trading at $1.72 per share. This represents the most recent stock quote for cbdMD, Inc.. Yesterday, cbdMD, Inc. closed at $1.66 per share.
In order to purchase cbdMD, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Signup to receive the latest stock alerts
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Shares of energy startup Bloom Energy (NYSE:BE) have advanced by…
Market Cap: $4.6T
P/E Ratio: 64x
Market Cap: $4T
P/E Ratio: 36x
Market Cap: $3.8T
P/E Ratio: 39x
Applied Optoelectronics, Inc. [AAOI] is up 3.95% over the past day.
Zenas BioPharma, Inc. [ZBIO] is up 1.18% over the past day.
UniFirst Corp. [UNF] is up 0.77% over the past day.